🔗 Share this article

The Nobel Prize in medical science was awarded for revolutionary findings that clarify how the immune system targets harmful infections while protecting the body's own cells.

A trio of esteemed researchers—Japan's Shimon Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this accolade.

The work identified specialized "security guards" within the immune system that remove malfunctioning immune cells capable of attacking the organism.

These findings are now enabling new treatments for immune disorders and malignancies.

These laureates will divide a monetary award valued at 11 million Swedish kronor.

Decisive Findings

"Their work has been decisive for comprehending how the body's defenses functions and the reason we don't all develop serious autoimmune diseases," commented the head of the award panel.

The trio's studies address a fundamental question: How does the immune system protect us from numerous infections while leaving our healthy cells intact?

The body's protection system employs immune cells that search for signs of infection, including viruses and bacteria it has never encountered.

Such defenders utilize sensors—known as recognition units—that are produced by chance in countless variations.

This provides the immune system the ability to fight a broad range of invaders, but the randomness of the mechanism inevitably creates immune cells that may target the body.

Protectors of the Immune System

Researchers previously knew that some of these problematic defense cells were eliminated in the thymus—where immune cells develop.

This year's award recognizes the discovery of T-reg cells—described as the immune system's "peacekeepers"—which travel through the body to disarm other defenders that attack the healthy cells.

It is known that this mechanism fails in self-attack conditions such as type-1 diabetes, MS, and RA.

The prize committee stated, "The discoveries have established a novel area of research and accelerated the creation of new therapies, for instance for cancer and immune disorders."

Regarding cancer, T-regs block the body from attacking the tumor, so research are aimed at lowering their quantity.

In autoimmune diseases, trials are testing increasing T-reg cells so the body is not being harmed. A similar method could also be useful in reducing the chances of transplanted organ rejection.

Pioneering Experiments

Prof Sakaguchi, from a Japanese institution, performed tests on mice that had their immune gland removed, causing self-attack conditions.

He demonstrated that introducing defense cells from other mice could prevent the disease—suggesting there was a system for blocking defenders from harming the body.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at a biotech firm in San Francisco, were investigating an genetic immune disorder in rodents and humans that resulted in the identification of a genetic factor vital for how regulatory T-cells function.

"The groundbreaking research has uncovered how the immune system is kept in check by T-reg cells, preventing it from mistakenly attacking the healthy cells," said a leading biological science expert.

"The work is a striking illustration of how fundamental biological study can have broad implications for human health."